SEOUL, April 11 (Korea Bizwire) – South Korea on Sunday decided to resume administering AstraZeneca vaccines to eligible recipients after temporarily putting the program on hold amid growing concerns over its safety. The use of AstraZeneca’s vaccine will resume Monday, except for those aged 30 and below, according to the Korea Disease Control and Prevention [...]
SEOUL, April 7 (Korea Bizwire) — South Korea decided Wednesday to suspend a AstraZeneca COVID-19 vaccination program for people younger than 60 due to concerns related to blood clots. Set to start on Thursday, AstraZeneca vaccination programs for special education instructors and teachers at kindergarten, elementary, middle and high schools, about 70,000 in total, will [...]
SEOUL, March 23 (Korea Bizwire) – President Moon Jae-in received his first dose of AstraZeneca’s COVID-19 vaccine Tuesday, as he plans to attend a Group of Seven (G-7) summit to be held in Britain. He received the shot at the Jongno-gu public health center near the presidential compound in Seoul, along with first lady Kim [...]
SEOUL, March 19 (Korea Bizwire) — South Korea is posed to speed up the rollout of the AstraZeneca COVID-19 vaccine as part of its inoculation campaign as the European Union’s medicines regulator assessed that there is no link to blood clots found in some recipients. The European Medicines Agency (EMA) announced Thursday (local time) that [...]
SEOUL, March 15 (Korea Bizwire) — President Moon Jae-in is scheduled to receive an AstraZeneca vaccine shot next week in preparation for participation in a Group of Seven (G-7) summit to be held in Britain, Cheong Wa Dae announced Monday, as health authorities here have decided to extend the use of the COVID-19 vaccine to [...]
SEOUL, March 11 (Korea Bizwire) — South Korea will expand the use of AstraZeneca’s COVID-19 vaccine to people aged 65 and older to ramp up the vaccine rollout as new overseas studies showed its effectiveness, health authorities said Thursday. The Korea Disease Control and Prevention Agency (KDCA) initially excluded administering vaccines developed by British-Swedish pharmaceutical [...]
SEOUL, March 8 (Korea Bizwire) — South Korea’s health authorities are likely to approve AstraZeneca’s COVID-19 vaccine for people aged 65 and older this week following the publication of new data overseas showing effectiveness. An independent panel under the health ministry has concluded that the AstraZeneca vaccine is OK for older people, following in the [...]
SHANGHAI, China, March 1 (Korea Bizwire) — Junshi Biosciences (HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development and commercialization of novel therapies, announced today that the Company has entered into an exclusive promotion agreement with AstraZeneca Pharmaceutical Co., Ltd. (“AstraZeneca Pharmaceutical” or the “Promoter”), pursuant to which Junshi Biosciences [...]
SEOUL, Feb. 15 (Korea Bizwire) — South Korea will begin its first inoculations against the new coronavirus on Feb. 26 with AstraZeneca’s COVID-19 vaccine, but the inoculation of seniors will be put on hold amid efficacy concerns, health authorities said Monday. The Korea Disease Control and Prevention Agency (KDCA) said people and patients, excluding those [...]
SEOUL, Feb. 10 (Korea Bizwire) — South Korea’s drug safety agency on Wednesday approved the vaccine for the novel coronavirus by AstraZeneca for all adults, including those aged 65 and older, amid efficacy controversies. The vaccine developed by the British-Swedish pharmaceutical giant and Oxford University is the first to be granted approval in the country, [...]